Dr Judd Alan Sparagon, DPM | |
113 Comanche Rd, Fort Meade, SD 57741-1002 | |
(605) 347-2511 | |
(605) 720-7238 |
Full Name | Dr Judd Alan Sparagon |
---|---|
Gender | Male |
Speciality | Podiatrist - Primary Podiatric Medicine |
Location | 113 Comanche Rd, Fort Meade, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245280643 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213EP1101X | Podiatrist - Primary Podiatric Medicine | 100 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Judd Alan Sparagon, DPM Po Box 7533, Rapid City, SD 57709-7533 Ph: (605) 347-2511 | Dr Judd Alan Sparagon, DPM 113 Comanche Rd, Fort Meade, SD 57741-1002 Ph: (605) 347-2511 |
News Archive
Sorrento Therapeutics, Inc. today announced that it has completed the construction of an extensive library of full-length, fully human monoclonal antibodies (mAbs). Initial analysis indicates a potential diversity of more than one trillion unique mAbs. The company believes this makes its library the largest full-length, fully human antibody library available for drug discovery and development partnerships.
"Halfway into their two-week annual meeting, delegates to the Commission on the Status of Women fear they will not be able to agree on a final communiqué, just like last year," a New York Times editorial writes.
superDimension, Inc.®, a private company that develops minimally invasive interventional pulmonology devices, announced today that The American Medical Association (AMA) has issued a new Category I CPT® code for the use of the Company's electromagnetic navigational bronchoscopy (ENB) device to navigate to lesions or spots deep in the lungs.
Researchers at the University of Iowa College of Dentistry are partnering with a private company to develop computer simulations that can help personalize cancer care by predicting how a patient will respond to a drug treatment.
The potential to use a patient's own cells to treat non-healing chronic wounds - a serious complication of diabetes - took an important step forward as researchers successfully reprogrammed skin cells taken from diabetic foot ulcers to form induced pluripotent stem cells (iPSCs).
› Verified 2 days ago